New study aims to catch type 1 diabetes early in At-Risk kids

NCT ID NCT07038473

Recruiting now Knowledge-focused Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is screening children and adolescents aged 1.5 to 18 years who have a parent or sibling with type 1 diabetes. Researchers will collect blood samples to look for early signs of the disease, such as specific autoantibodies, before symptoms appear. The goal is to identify pre-symptomatic type 1 diabetes and improve monitoring and data collection in Gulf countries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early detection and monitoring of type 1 diabetes in at-risk children, potentially allowing for earlier intervention.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change outcomes, and the results might not apply to all populations or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01
RECRUITING

Jeddah, Mecca Region, Saudi Arabia
Sheikh Shakhbout Medical City - Site Number: 06
RECRUITING

Abu Dhabi, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.